Shares of TELA Bio TELA rose in after-market trading after the company reported Q1 results.
Quarterly Results
Earnings per share were up 11.11% year over year to ($0.56), which missed the estimate of ($0.48).
Revenue of $5,877,000 up by 57.73% year over year, which beat the estimate of $5,460,000.
Outlook
Earnings guidance hasn't been issued by the company for now.
Revenue guidance hasn't been issued by the company for now.
Details Of The Call
Date: May 13, 2021
Time: 04:30 PM
ET Webcast URL: https://edge.media-server.com/mmc/p/9ykqb5zc
Technicals
Company's 52-week high was at $23.55
52-week low: $10.77
Price action over last quarter: down 8.88%
Company Description
TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
